Implant Sciences Selected by U.S. Department of Commerce for Trade Mission to Brazil
Mission Represents Entry Into Brazil's $24 B Security Market 07/28 07:00 AM
WILMINGTON, MA -- (MARKET WIRE) -- 07/28/10 -- Implant Sciences Corporation (IMSC:$0.3600,$0.0000,0.00%) , a high technology supplier of systems and sensors for the homeland security and defense markets, today announced that is has been selected by the Department of Commerce to be part of a small group of leading companies participating in a Safety and Security trade mission to Brazil on September 26 through 30, 2010.
Brazil is the fifth largest security market in the world, with an estimated $24 billion being invested in security for 2010.
In the coming years this number is expected to grow significantly, driven by events including the World Cup in 2014 and the Summer Olympics in 2016. Implant Sciences (IMSC:$0.3600,$0.0000,0.00%) , a key provider of security solutions to the 2008 Beijing Olympics, approaches the trade mission with a significant competitive advantage.
For the trade mission, the Department of Commerce is arranging meetings for Implant Sciences (IMSC:$0.3600,$0.0000,0.00%) with potential channel partners, customers, and regulatory officials. Implant Sciences (IMSC:$0.3600,$0.0000,0.00%) will pursue sales of its leading security products, including the Quantum Sniffer?, to Brazil in the transportation and aviation security, force protection and law enforcement, critical infrastructure protection, and public safety markets.
"We are pleased to have been selected to participate in this high profile trade mission. Brazil is an important target market for us, and our experience in Beijing, in advance of the 2008 Olympics, has taught us that our 'best of breed' ETD solutions offer compelling operational advantages in real world security environments. We look forward to quickly engaging in the growing Brazilian security market," stated Jeff Tehan, Vice President of Sales and Marketing for Implant Sciences (IMSC:$0.3600,$0.0000,0.00%) .
Glenn D. Bolduc, Implant Sciences (IMSC:$0.3600,$0.0000,0.00%) CEO, commented, "The quality and effectiveness of our security products, combined with our newly fortified sales and marketing team are leading to an increasing number of revenue opportunities for Implant Sciences (IMSC:$0.3600,$0.0000,0.00%) . As the fifth largest market in security, Brazil is a key market where we anticipate significant traction."
About Implant Sciences (IMSC:$0.3600,$0.0000,0.00%)
Implant Sciences (IMSC:$0.3600,$0.0000,0.00%) develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Science's QS-H100 and QS-H150 Portable Explosives Detectors have been Designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com
Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the U.S. government or by other law enforcement agencies or commercial consumers of security products; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact:
Implant Sciences Corporation (IMSC:$0.3600,$0.0000,0.00%)
Company Contact:
Glenn Bolduc
CEO
978-752-1700
Email Contact
or
Investor Contact:
Laurel Moody
646-810-0608
Email Contact
Get more news on:SYMBOLS: IMSCNEWS TYPE: SECTORS: Health Care Equipment and Supplies, Health Care, Electronic Equipment and Instruments, Information Technology, Electrical Equipment, Industrials
